Refer A Patient

Request An Appointment

Neurology

OCREVUS

OCREVUS (ocrelizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells.
Infusion or injection therapy referral
What it treats Multiple Sclerosis
Prescribed by Neurologists
How it’s administered Intravenous (IV) infusion
Frequency Once every six months
Length of treatment Five hours or more

About This Therapy

OCREVUS (ocrelizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells. This may help to protect healthy cells from damage. Specifically, it is a CD20-cytolytic antibody for the treatment of Multiple Sclerosis (MS).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

OCREVUS REFERRAL FORM

OCREVUS REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for OCREVUS

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.